ALAD Porphyria Treatment Market

Key Players

• Recordati Rare Diseases Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson & AND companies IS NULL; Johnson
• Mylan N.V.
• AstraZeneca Plc. and others